Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53
- PMID: 7729416
- PMCID: PMC398223
- DOI: 10.1002/j.1460-2075.1995.tb07124.x
Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53
Abstract
Epstein-Barr virus (EBV) efficiently converts resting human B cells into actively cycling, immortal, lymphoblastoid cell lines (LCLs). Here we show that LCLs expressing the full complement of latent viral genes are very sensitive to DNA-damaging agents such as cisplatin. The response includes a rapid accumulation of the tumour suppressor protein p53 and induction of the cellular genes mdm2 and WAF1/p21. Although the levels of Bcl2 protein and Bax mRNA appear unaltered by the activation of p53, within 24 h the majority of cells undergo apoptosis. Over-expression of wild-type p53 in an LCL also resulted in apoptosis; this was preceded by the dephosphorylation of the retinoblastoma gene product, pRb. Primary resting B cells showed no response to cisplatin and even after drug treatment, p53 remained undetectable. However, after infection with EBV, p53 gene expression was induced to a similar level to that found in mitogen-activated B cells. When the physiologically activated primary B cells were exposed to cisplatin, although p53 accumulated as in LCLs, the outcome was growth-arrest rather than gross cell death. We conclude that, in contrast to the transformation of fibroblasts by adenovirus, SV40 or HPV, when B cells become activated and immortalized by EBV they are sensitized to the p53-mediated damage response. When the resulting LCLs are treated with genotoxic agents such as cisplatin, they are unable to arrest like normal cells because they are driven to proliferate by EBV and consequently undergo apoptosis.
Similar articles
-
Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):352-6. doi: 10.1073/pnas.90.1.352. Proc Natl Acad Sci U S A. 1993. PMID: 8380497 Free PMC article.
-
MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.J Virol. 2009 Mar;83(6):2491-9. doi: 10.1128/JVI.01681-08. Epub 2009 Jan 14. J Virol. 2009. PMID: 19144715 Free PMC article.
-
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2.Oncogene. 2003 Oct 16;22(46):7181-91. doi: 10.1038/sj.onc.1206838. Oncogene. 2003. PMID: 14562046
-
Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.Cancer Res. 2004 May 15;64(10):3361-4. doi: 10.1158/0008-5472.CAN-04-0079. Cancer Res. 2004. PMID: 15150084 Review.
-
Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Eur J Cell Biol. 2012. PMID: 21450364 Review.
Cited by
-
Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins.J Mol Med (Berl). 1995 Nov;73(11):529-38. doi: 10.1007/BF00195138. J Mol Med (Berl). 1995. PMID: 8751137 Review.
-
Transcription abnormalities potentiate apoptosis of normal human fibroblasts.Mol Med. 1997 Dec;3(12):852-63. Mol Med. 1997. PMID: 9440118 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity.J Virol. 1996 Jul;70(7):4849-53. doi: 10.1128/JVI.70.7.4849-4853.1996. J Virol. 1996. PMID: 8676521 Free PMC article.
-
Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.J Virol. 2006 Dec;80(24):12408-13. doi: 10.1128/JVI.01363-06. Epub 2006 Sep 20. J Virol. 2006. PMID: 16987979 Free PMC article.
-
How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?Semin Cancer Biol. 2009 Dec;19(6):366-76. doi: 10.1016/j.semcancer.2009.07.007. Epub 2009 Jul 25. Semin Cancer Biol. 2009. PMID: 19635566 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous